Drug Use Review (DUR) Board
Formulary Committee
2025 Agendas
June 18, 2025
May 21, 2025
April 16, 2025
March 19, 2025
February 12, 2025
2024 Agendas
December 4, 2024
September 25, 2024
June 19, 2024 Rev. 06/06/20224
May 22, 2024
April 17, 2024
March 13, 2024
February 14, 2024
2023 Agendas
October 25, 2023
August 9, 2023
May 24, 2023
April 26, 2023
March 15, 2023
February 15, 2023
2022 Agendas
November 9, 2022
September 21, 2022
July 13, 2022
May 25, 2022 Rev. 05/05/2022
April 27, 2022
March 23, 2022
February 23, 2022 Rev. 02/09/2022
2021 Agendas
November 10, 2021September 22, 2021
July 21, 2021
May 26, 2021
April 21, 2021 rev/ 04/06/2021
- Cosentyx® (secukinumab)
- EPCLUSA® (sofosbuvir and velpatasvir)
- EUCRISA® (crisaborole)
- DUPIXENT® (dupilumab)
March 24, 2021
February 3, 2021
2020 Agendas
December 9, 2020October 21, 2020
September 23, 2020
May 20, 2020 rev. 05/08/2020 April 22, 2020
March 25, 2020 - Updated 03/23/2020
2025 Minutes
June 18, 2025
May 21, 2025
April 16, 2025
March 19, 2025
February 12, 2025
2024 Minutes
December 4, 2024
September 25, 2024
June 19, 2024
May 22,2024
April 17,2024
March 13,2024
February 14,2024
2023 Minutes
October 25,2023
August 9, 2023 Amended
May 24, 2023
April 26,2023
March 15, 2023
February 15, 2023
2022 Minutes
November 9, 2022
September 21, 2022
July 13, 2022
May 25, 2022
April 27, 2022
March 23, 2022
February 23, 2022
2021 Minutes
November 09, 2021
September 22,2021
July 21, 2021
May 26, 2021
April 21, 2021
March 24, 2021
February 3, 2021
2020 Minutes
December 9, 2020October 21, 2020
September 23, 2020
May 20, 2020
April 22, 2020
March 25, 2020
January 22, 2020